Bioteque Balance Sheet Health
Financial Health criteria checks 5/6
Bioteque has a total shareholder equity of NT$3.3B and total debt of NT$483.7M, which brings its debt-to-equity ratio to 14.7%. Its total assets and total liabilities are NT$4.5B and NT$1.2B respectively. Bioteque's EBIT is NT$646.9M making its interest coverage ratio -208.6. It has cash and short-term investments of NT$1.4B.
Key information
14.7%
Debt to equity ratio
NT$483.68m
Debt
Interest coverage ratio | -208.6x |
Cash | NT$1.44b |
Equity | NT$3.29b |
Total liabilities | NT$1.20b |
Total assets | NT$4.49b |
Recent financial health updates
Recent updates
A Look At The Fair Value Of Bioteque Corporation (GTSM:4107)
Apr 26Should You Buy Bioteque Corporation (GTSM:4107) For Its Dividend?
Mar 29Bioteque Corporation's (GTSM:4107) Fundamentals Look Pretty Strong: Could The Market Be Wrong About The Stock?
Mar 11The Trends At Bioteque (GTSM:4107) That You Should Know About
Feb 24Update: Bioteque (GTSM:4107) Stock Gained 51% In The Last Three Years
Feb 09Estimating The Intrinsic Value Of Bioteque Corporation (GTSM:4107)
Jan 25Bioteque (GTSM:4107) Has A Rock Solid Balance Sheet
Jan 10Does Bioteque Corporation (GTSM:4107) Have A Place In Your Dividend Portfolio?
Dec 25Are Bioteque Corporation's (GTSM:4107) Fundamentals Good Enough to Warrant Buying Given The Stock's Recent Weakness?
Dec 10Will Bioteque (GTSM:4107) Multiply In Value Going Forward?
Nov 22Financial Position Analysis
Short Term Liabilities: 4107's short term assets (NT$2.1B) exceed its short term liabilities (NT$528.8M).
Long Term Liabilities: 4107's short term assets (NT$2.1B) exceed its long term liabilities (NT$675.0M).
Debt to Equity History and Analysis
Debt Level: 4107 has more cash than its total debt.
Reducing Debt: 4107's debt to equity ratio has increased from 3.3% to 14.7% over the past 5 years.
Debt Coverage: 4107's debt is well covered by operating cash flow (147.3%).
Interest Coverage: 4107 earns more interest than it pays, so coverage of interest payments is not a concern.
Balance Sheet
Discover healthy companies
Company Analysis and Financial Data Status
Data | Last Updated (UTC time) |
---|---|
Company Analysis | 2024/12/23 09:04 |
End of Day Share Price | 2024/12/23 00:00 |
Earnings | 2024/09/30 |
Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
Package | Data | Timeframe | Example US Source * |
---|---|---|---|
Company Financials | 10 years |
| |
Analyst Consensus Estimates | +3 years |
|
|
Market Prices | 30 years |
| |
Ownership | 10 years |
| |
Management | 10 years |
| |
Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Bioteque Corporation is covered by 5 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
Analyst | Institution |
---|---|
Zhennan Lee | Jih Sun Securities Investment Consulting Co., Ltd. |
Ming Hong Chu | KGI Securities Co. Ltd. |
Hsiu Chi Lin | Masterlink Securities Corp. |